M. Mévélec

发表

Key Limitations and New Insights Into the Toxoplasma gondii Parasite Stage Switching for Future Vaccine Development in Human, Livestock, and Cats

Z. Lakhrif, I. Dimier-Poisson, M. Mévélec, 2020, Frontiers in Cellular and Infection Microbiology.

Detection of a novel 40 000 MW excretory Toxoplasma gondii antigen by murine Th1 clone which induces toxoplasmacidal activity when exposed to infected macrophages

J. Dubremetz, G. Reichmann, H. Fischer, 1997, Immunology.

HBsAG POSITIVE REACTIVITY IN MAN NOT DUE TO HEPATITIS B VIRUS

B. Yvonnet, P. Coursaget, J. Chiron, 1987, The Lancet.

Neospora caninum: a new class of biopharmaceuticals in the therapeutic arsenal against cancer

N. Moiré, T. Baranek, T. Kervarrec, 2020, Journal for ImmunoTherapy of Cancer.

Apoptotic pulsed dendritic cells induce a protective immune response against Toxoplasma gondii

M. Grégoire, P. Berthon, I. Dimier-Poisson, 2008, Parasite immunology.

Engineering and functional evaluation of neutralizing antibody fragments against congenital toxoplasmosis.

N. Aubrey, G. Desoubeaux, Z. Lakhrif, 2021, The Journal of infectious diseases.

Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant.

I. Dimier-Poisson, M. Mévélec, J. W. Judge, 2009, Vaccine.

Identification of two alleles in the GRA4 locus of Toxoplasma gondii determining a differential epitope which allows discrimination of type I versus type II and III strains.

J. Dubremetz, G. Reichmann, H. Fischer, 1996, Molecular and biochemical parasitology.

[Vaccines on mucosal surfaces].

D. Bout, F. Velge-Roussel, M. Lebrun, 2003, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Protective Mucosal Th2 Immune Response against Toxoplasma gondii by Murine Mesenteric Lymph Node Dendritic Cells

D. Bout, D. Buzoni‐Gatel, C. Beauvillain, 2003, Infection and Immunity.

Amplification of the secretory IgA response to Toxoplasma gondii using cholera toxin.

J. Woodman, D. Bout, T. Chardès, 1991, FEMS microbiology letters.

Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens

J. Dubremetz, D. Bout, T. Chardès, 1990, Infection and immunity.

Nasal immunization of mice with Cryptosporidium parvum DNA induces systemic and intestinal immune responses

D. Bout, S. Iochmann, I. Dimier-Poisson, 1999, Parasite immunology.

Further analysis of protection induced by the MIC3 DNA vaccine against T. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection.

M. Lebrun, I. Dimier-Poisson, M. Mévélec, 2009, Vaccine.

A novel CD4–CD8α+CD205+CD11b– murine spleen dendritic cell line: establishment, characterization and functional analysis in a model of vaccination to toxoplasmosis

P. Roingeard, D. Bout, C. Beauvillain, 2005, Cellular microbiology.

Mic1-3 knockout of Toxoplasma gondii is a successful vaccine against chronic and congenital toxoplasmosis in mice.

J. Dubremetz, D. Bout, M. Lebrun, 2006, The Journal of infectious diseases.

The MIC3 Gene of Toxoplasma gondii Is a Novel Potent Vaccine Candidate against Toxoplasmosis

C. Collin, D. Bout, M. Mévélec, 2003, Infection and Immunity.

Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice.

Rémy Magné, O. Bruneel, D. Bout, 2005, Vaccine.

Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene.

D. Bout, D. Buzoni‐Gatel, M. Mévélec, 2000, Vaccine.

Molecular cloning of GRA4, a Toxoplasma gondii dense granule protein, recognized by mucosal IgA antibodies.

J. Dubremetz, O. Mercereau‐Puijalon, D. Bout, 1992, Molecular and biochemical parasitology.

Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route

N. Moiré, I. Dimier-Poisson, M. Mévélec, 2017, Medical Microbiology and Immunology.

Mic1-3 Knockout Toxoplasma gondii is a good candidate for a vaccine against T. gondii-induced abortion in sheep

D. Bout, M. Lebrun, I. Dimier-Poisson, 2010, Veterinary research.

Induction of protective immunity against toxoplasmosis in mice by immunization with Toxoplasma gondii RNA.

D. Bout, I. Dimier-Poisson, F. Aline, 2006, Vaccine.

Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis.

N. Moiré, I. Dimier-Poisson, J. Pierre, 2011, Vaccine.

Protection against Lethal Neospora caninum Infection in Mice Induced by Heterologous Vaccination with a mic1 mic3 Knockout Toxoplasma gondii Strain

T. Fandeur, I. Dimier-Poisson, M. Mévélec, 2009, Infection and Immunity.

Co-delivery of PLGA nanoparticles loaded with rSAG1 antigen and TLR ligands: An efficient vaccine against chronic toxoplasmosis.

I. Dimier-Poisson, M. Mévélec, Pezhman Fard-Esfahani, 2021, Microbial pathogenesis.

Targeted Delivery of Toxoplasma gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency against Toxoplasmosis

N. Moiré, B. Hérault, Alexis Moreau, 2018, Front. Immunol..

Mucosal and systemic cellular immune responses induced by Toxoplasma gondii antigens in cyst orally infected mice.

D. Bout, F. Velge-Roussel, T. Chardès, 1993, Immunology.

The antigen-specific response to Toxoplasma gondii profilin, a TLR11/12 ligand, depends on its intrinsic adjuvant properties

N. Moiré, F. Laurent, I. Dimier-Poisson, 2016, Medical Microbiology and Immunology.

Serum and secretory IgA antibodies specific for Toxoplasma gondii: kinetics of the murine humoral response to infection and characterisation of target antigens

J. Dubremetz, D. Bout, T. Chardès, 1990 .

Nasal administration of recombinant Neospora caninum secreting IL-15/IL-15Rα inhibits metastatic melanoma development in lung

N. Moiré, M. Samimi, M. Epardaud, 2023, Journal for ImmunoTherapy of Cancer.

The antigen-specific response to Toxoplasma gondii profilin, a TLR11/12 ligand, depends on its intrinsic adjuvant properties

N. Moiré, F. Laurent, I. Dimier-Poisson, 2016, Medical Microbiology and Immunology.

Prospects for a human Toxoplasma vaccine.

D. Bout, F. Velge-Roussel, M. Lebrun, 2002, Current drug targets. Immune, endocrine and metabolic disorders.

Exploration and Modulation of Antibody Fragment Biophysical Properties by Replacing the Framework Region Sequences

M. Pugnière, N. Aubrey, C. Henriquet, 2020, Antibodies.